Eyetube Podcasts

Listen as Damien F. Goldberg, MD; Denise M. Visco, MD; and Eric Rosenberg, DO, MScEng, read highlights of the July issue of CRST, including the evolution of steroid use in cataract surgery, effective pre- and postoperative drug regimens, and the evolution of 3D visualization platforms.

Approaches to treating retinitis pigmentosa have included prosthetic devices and gene therapy. What if there was an approach that could treat the nearly 2 million worldwide patients with disease? Anthony Joseph, MD, discusses jCell technology, which may work independently of a patient's genetic subtype to promote photoreceptor survival in retinitis pigmentosa patients. What data from a phase 2b trial were used to evaluate the efficacy of jCell technology? How will the therapy be tested going forward? What safety concerns should clinicians be aware of? Dr. Joseph has some answers.

A COVID-19 resurgence seems increasingly likely as autumn and winter approach the United States, forcing people indoors and increasing transmission risk. What can retina clinicians learn from the spring and summers waves of COVID-19 infections that could be applied to the cooler months of 2020? John W. Kitchens, MD, invites Steve Charles, MD; Amy Schefler, MD; and Jayanth Sridhar, MD, to gameplan the future of retina clinics.

Retina's ability to adjust to a new environment should be commended. Which of the technologies introduced during the COVID-19 era are stopgaps and which will be a permanent part of the treatment landscape? John W. Kitchens, MD (United States), is joined by María H. Berrocal, MD (United States); Jean-Francois Korobelnik, MD, PhD (France); and Manish Nagpal, MBBS, MS, FRCS (Edin) (India), to forecast the future of retina's technologic milieu.

If you're looking to relax to the sweet sounds of your colleagues talking about diagnosing and treating ocular surface disease, then this is the episode for you! All of these articles can be found in the July/August issue of Modern Optometry and are read by the authors themselves. First up is Damon Dierker, OD, FAAO, with a summary of the latest innovations in dry eye treatment (0:56), followed by Seema Nanda, OD, who has some great tips for differentiating between Sjögren syndrome dry eye and non-Sjögren syndrome dry eye (9:37). The next article in the episode is from the issue's subfocus on the female eye, but also crosses into the realm of ocular surface disease. Tracy Doll, OD, FAAO, provides an examination of the changing ocular surface through the stages of life (21:32). Last but not least, no episode would be complete without the latest addition of our Up Close column (31:35). This time you'll learn all about MOD's own Leslie O'Dell, OD, FAAO.

Treat-and-extend therapy is a common tactic employed by retina specialists for treating wet AMD patients. What new data will grow the body of information retina specialists already draw on when making decisions about treatment regimen? Michael Singer, MD, shares details from a retrospective review of patient data over a 2-year period during which treat-and-extend regimens were employed.

Knowing what to do when confronted with a dry eye masquerader can go a long way to ensuring better patient outcomes. Working their way in from the outside of the eye, starting with the lid and ending with the cornea, hosts Leslie and Jackie discuss how to identify and manage conditions that can masquerade or contribute to dry eye and complicate a patient's treatment plan.

Ahmad Aref, MD, MBA, provides an update on the complex relationship between cannabis ingestion and glaucomatous optic neuropathy, as featured in the July/August 2020 issue of Glaucoma Today.

In this episode, cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, are joined by ophthalmology's favorite comedian, Dr. Glaucomflecken. Dr. G talks about how comedy started as his creative outlet and led to him becoming the comedic voice of medicine on Twitter. He also shares how he has used humor to help him cope with personal adversity.

William Wiley, MD; Kourtney Houser, MD; and Blake Williamson, MD, join Marguerite McDonald, MD, FACS, to discuss the value of toric IOLs, when to use these lenses versus an incisional approach, and how to educate patients about astigmatic correction.